
HNMC — Investor Relations & Filings
Heron Neutron Medical Corp. specializes in the development and deployment of Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) systems. The company provides end-to-end integrated solutions for oncology, encompassing the design and manufacture of high-precision accelerator systems, neutron beam moderators, treatment planning software, and treatment control systems. Its core technology facilitates targeted radiation therapy designed to maximize efficacy while minimizing treatment duration and side effects for cancer patients. Heron Neutron Medical is a pioneer in the commercialization of large-scale medical equipment, offering a comprehensive technology platform that includes both hardware and specialized boron-containing drugs. Through collaborations with clinical and academic institutions, the company focuses on establishing advanced BNCT centers to expand the availability of precision care and innovative cancer treatment options.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 本公司研發之B10 L-BPA 注射液向台灣衛生福利部食品藥物 管理署(TFDA)提出復發性局部晚期或轉移性三陰性乳癌之學術研 究用人體臨床試驗審查申請(IND) | 2026-05-25 | Chinese | |
| 115年5月11日內部人設質解質 | 2026-05-12 | Chinese | |
| 115年第1季權益變動表 | 2026-04-29 | English | |
| 115年第1季現金流量表 | 2026-04-29 | Chinese | |
| 115年第1季綜合損益表 | 2026-04-29 | Chinese | |
| 115年第1季資產負債表 | 2026-04-29 | Chinese |
Browse filings by year
1 year| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47013863 | 本公司研發之B10 L-BPA 注射液向台灣衛生福利部食品藥物 管理署(TFDA)提出復發性局部晚期或轉移性三陰性乳癌之學術研 究用人體臨床試驗審查申請(IND) | 2026-05-25 | Chinese | ||
| 46124727 | 115年5月11日內部人設質解質 | 2026-05-12 | Chinese | ||
| 38496377 | 115年第1季權益變動表 | 2026-04-29 | English | ||
| 38496360 | 115年第1季現金流量表 | 2026-04-29 | Chinese | ||
| 38496340 | 115年第1季綜合損益表 | 2026-04-29 | Chinese | ||
| 38496318 | 115年第1季資產負債表 | 2026-04-29 | Chinese | ||
| 36181426 | 115年年報及股東會資料 — 2026_7799_20260527F13.pdf | 2026-04-24 | Chinese | ||
| 36181385 | 115年年報及股東會資料 — 2026_7799_20260527FE2.pdf | 2026-04-24 | English | ||
| 36181342 | 115年年報及股東會資料 — 2026_7799_20260527F02.pdf | 2026-04-24 | Chinese | ||
| 36181300 | 115年年報及股東會資料 — 2026_7799_20260527F01.pdf | 2026-04-24 | Chinese | ||
| 35966358 | 115年第1季財務報告書 — 202601_7799_AI1.pdf | 2026-04-24 | Chinese | ||
| 35966973 | 114年第4季財務報告書 — 202504_7799_AIB.pdf | 2026-04-24 | English | ||
| 35966921 | 114年第4季財務報告書 — 202504_7799_AI2.pdf | 2026-04-24 | Chinese | ||
| 35966722 | 114年第4季財務報告書 — 202503_7799_AIB.pdf | 2026-04-24 | English | ||
| 35966671 | 114年第4季財務報告書 — 202503_7799_AI2.pdf | 2026-04-24 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of irradiation, electromedical and electrotherapeutic equipment
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Nestmedic Spolka Akcyjna
Develops a telemedical system for remote fetal monitoring u…
|
NST | PL | Manufacturing |
|
Neuraxis, INC
Develops neuromodulation therapies for disorders of gut-bra…
|
NRXS | US | Manufacturing |
|
NEUROONE MEDICAL TECHNOLOGIES Corp
Develops thin-film electrodes for neurological diagnosis, t…
|
NMTC | US | Manufacturing |
|
NeuroPace Inc
Develops an FDA-approved brain-responsive neurostimulation …
|
NPCE | US | Manufacturing |
|
Nexalin Technology, Inc.
Develops non-invasive neurostimulation devices for mental a…
|
NXL | US | Manufacturing |
|
Nexstim Oyj
Develops non-invasive brain stimulation systems for therapy…
|
NXTM | FI | Manufacturing |
|
NIHON KOHDEN CORPORATION
Develops, manufactures, and distributes medical electronic …
|
6849 | JP | Manufacturing |
|
NINGBO JANSEN SUPERCONDUCTING TECHNOLOGIES CO., LTD.
Develops superconducting magnets and cryogenic tech for med…
|
688805 | CN | Manufacturing |
|
NIR Diagnostics Inc.
Creates non-invasive, hand-held diagnostic devices using ne…
|
NID-X | CA | Manufacturing |
|
NORTECH SYSTEMS INC
Electronics manufacturing services for complex electromecha…
|
NSYS | US | Manufacturing |
HNMC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/52702/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=52702 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=52702 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=52702 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 52702}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for HNMC (id: 52702)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.